Suppression of human immunodeficiency virus type 1 viral load during acute measles

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 63-65

  Moss, William J ^a   Scott, Susana ^a   Ndhlovu, Zaza ^b   Monze, Mwaka ^c   Cutts, Felicity T ^a   Quinn, Thomas C ^d   Griffin, Diane E ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

HIV 1; Measles

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CHILD HOSPITALIZATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MEASLES; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; VIRUS LOAD; ZAMBIA;

ACUTE DISEASE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD; ZAMBIA;

EID: 66149115528     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318184eed2     Document Type: Article

References (10)

1. Moss WJ, Ryon JJ, Monze M, et al. Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis. 2002;185:1035-1042.
2. Moss WJ, Scott S, Mugala N, et al. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis. 2007;196:347-355.
3. Ruel TD, Achan J, Gasasira AF, et al. HIV RNA suppression among HIV-infected Ugandan children with measles. J Acquir Immune Defic Syndr. 2008;48:225-227.
4. Centers for Disease Control and Prevention (CDC). Progress in measles control-Zambia, 1999-2004. MMWR Morb Mortal Wkly Rep. 2005;54:581-584.
5. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997;387:188-191.
6. Luzuriaga K, Wu H, McManus M, et al. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol. 1999; 73:362-367.
7. Palumbo P, Wu H, Chadwick E, et al. Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection. J Infect Dis. 2007;196:23-29.
8. Grivel JC, Garcia M, Moss WJ, et al. Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. J Infect Dis. 2005;192: 71-78.
9. Garcia M, Yu XF, Griffin DE, et al. In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. J Virol. 2005;79:9197-9205.
10. Garcia M, Yu XF, Griffin DE, et al. Measles virus inhibits HIV-1 reverse transcription and productive replication by blocking cell cycle progression of CD4- T-lymphocytes. J Gen Virol. 2008;89(Pt 4):984-993.